Skip to main content
SpringerLink
Log in

Comparative Trial of Ketanserin or Bendrofluazide as Add-On Therapy in Hypertensive Patients Uncontrolled on a β-Blocker Alone

  • Short Communication
  • Poster Presentations: Ketanserin in Essential Hypertension
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bulpitt CJ, Dollery CT, Carne S. A symptom questionnaire for hypertensive patients. Journal of Chronic Diseases 27: 309–323, 1974

    Article  PubMed  CAS  Google Scholar 

  • Cameron HA, Ramsay LE. Ketanserin in essential hypertension: a double blind placebo controlled study. Postgraduate Medical Journal 61: 583–586, 1985

    Article  PubMed  CAS  Google Scholar 

  • Hedner T, Persson B. Ketanserin in combination with β-adrenergic receptor blocking agents in the treatment of essential hypertension. British Journal of Clinical Pharmacology 18: 765–771, 1984

    Article  PubMed  CAS  Google Scholar 

  • Idzikowski CI, Cowen PJ, Nutt D, Mills FJ. The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan. Psychopharmacology 93: 416–420, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kaplan NM. Clinical hypertension, 4th ed. Williams and Wilkins, 1986

  • Medical Research Council (MRC) Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 2: 539, 1981

    Google Scholar 

  • Rosendorff C, Murray GD. Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: only ketanserin’s hypotensive effect is age related. Journal of Hypertension 4(Suppl. 6): S109–S111, 1986

    Google Scholar 

  • Schalekamp MADH, Woittiez AJJ, Wenting GJ, van den Meiraker AH, Man in’t Veld AJ. Ketanserin: haemodynamic effects and mechanism of action. Journal of Hypertension 4(Suppl. 11): S7–S12, 1986

    PubMed  CAS  Google Scholar 

  • Tomlinson IW. Monitoring cutaneous circulation in Raynaud’s phenomenon with observations on ketanserin. Advances in Microcirculation 12: 37–52, 1985

    Google Scholar 

  • Turner JF, Gould SE, Welburn PJ, Whitehead PA. The effect of antihypertensive treatment on the assessment of well-being in a general practice population. Journal of Hypertension 5(Suppl. 5): S529–S531, 1987

    Google Scholar 

  • Van Nueten JM, Janssens WJ. Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin. Journal of Hypertension 4(Suppl. 1): S55–S59, 1986

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pike View Medical Centre, Horwich, UK

    K. Korlipara

  2. Janssen Pharmaceutical Ltd, Grove, Wantage, Oxon, OX12 ODQ, UK

    Susan E. Gould, N. A. Taylor & T. C. Chandler

Authors
  1. K. Korlipara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan E. Gould
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. A. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. C. Chandler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korlipara, K., Gould, S.E., Taylor, N.A. et al. Comparative Trial of Ketanserin or Bendrofluazide as Add-On Therapy in Hypertensive Patients Uncontrolled on a β-Blocker Alone. Drugs 36 (Suppl 1), 130–134 (1988). https://doi.org/10.2165/00003495-198800361-00026

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800361-00026

Keywords

Search

Navigation